NCT00076843View on ClinicalTrials.gov

Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

February 3, 2004

Primary Completion Date

October 11, 2017

Study Completion Date

June 25, 2019

Conditions
HTLV-1
Interventions
DRUG

Hu MiK-Beta-1

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00076843 - Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis | Biotech Hunter | Biotech Hunter